Navigation Links
Computers help chemists fight emerging infections
Date:8/19/2007

BOSTON, Aug. 19, 2007 Computer analysis of existing drugs may be key to fighting new infectious agents and antibiotic-resistant pathogens like deadly tuberculosis strains and staph superbugs. Researchers in Canada say the use of such emergency discovery technology could save time, money and lives during a sudden outbreak or a bioterrorism attack. They reported here today at the 234th national meeting of the American Chemical Society.

Drug repurposing or reprofiling is not new: Pharmaceutical companies have been seeking new uses of old drugs to extend patent protections and whenever new, off-label uses of the drugs are found. But reprofiling to deliberately develop emergency drugs is a new concept, made possible by advances in chemoinformatics, a new field that merges chemistry with computer science, according to study presenter Artem Cherkasov, Ph.D., of the University of British Columbia in Vancouver, Canada.

In the case of new infectious threats, there might be no time to develop a completely new drug from the ground up, as the corresponding toxicological studies and regulatory investigations will take years to complete properly, says Cherkasov, a chemist with a background in computer-aided drug design and infectious disease. Finding an already existing, well-studied therapeutic agent that will kill an emerging bug might provide a rapid, first line of defense response option.

Under the new computer-aided system, the researchers plan to first identify vulnerable cellular components of a pathogen using proteomics, or the study of proteins and their interactions. They will enter these key structures into the computer and, using elements of modern Artificial Intelligence, will identify drugs that have the highest potential for activity against the target and for antimicrobial activity, says Cherkasov. Those compounds with the highest ranking can then be quickly tested in the laboratory against the pathogen and eventually used to treat infected individuals, the researcher says.

The new approach is still in development for possible future use during an actual outbreak, Cherkasov notes. However, many non-antibiotic drugs have been shown to have antibiotic-like properties using this technique, he says. For example, computer studies have suggested that lovastatin, a drug marketed to lower cholesterol, and gentisic acid, an anti-inflammatory drug related to aspirin, both show promise as strong antibiotics. But more studies are needed before these compounds can be recommended for use as antibiotics in a clinical setting, he adds.

It is not totally unexpected as there are thousands of existing drugs that are already enriched with target-binding structural features, Cherkasov says. Many of them were not designed as antibiotics but have the potential to act as such.

The chemical structures of compounds we identify usually look nothing like known antibiotics. But if a compound behaves like antibiotic in a computational model, it may act as one in a real life, says Cherkasov, who has programmed his computer system to identify antibiotic likeness, or those chemical structures which have the most potential for antibiotic activity.

There is a growing need to expand and complement the range of available antimicrobial compounds, as many big pharmaceutical companies have withdrawn from the field of anti-infective agents, according to Cherkasov. Only two novel antibiotics have entered the market in the last 20 years, he says.

The researchers plan to soon begin testing some of the newly identified antibiotic candidates against methicillin-resistant Staphylococcus aureus (MRSA). Also known as superbugs, these bacteria are an increasingly worrisome cause of serious hospital-based infections and infections acquired in community settings.

Although Cherkasovs research team specializes in battling bacterial infections, similar techniques can be applied to emerging viral infections, such as SARS and bird flu, he says. Likewise, the technique also provides a potential means of identifying quick treatments for bioterrorism agents, such as new strains of anthrax, as well as rare infectious diseases such as those sometimes encountered in third-world countries.


'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-4400
American Chemical Society
Source:Eurekalert

Related medicine news :

1. Computers may become surgeons
2. Risk of DVT for those spending long hours in front of computers
3. Elderly People Can Take Up Computers To Fight Depression
4. Computers Can Teach Patients About Screening for Cancer
5. From Computers to Vaccines
6. Supercomputers To Assist In Thwarting Bird Flu Epidemic In Future
7. Computers Aid in the Development of Bird Flu Vaccine
8. Dispensing Drug Dosage To Children Through Computers
9. Better Communication Ensured Between Humans and Computers
10. Sleeping Computers Yield Clues About Genetic Disorders
11. Computers Assist Breast Cancer Screening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2016)... ... May 29, 2016 , ... Whole Health Supply is happy ... that has been available via Amazon.com. This new style of nail clipper has a ... jaw opening is approximately 4mm and the actual handle is 2.5mm thick to accommodate ...
(Date:5/29/2016)... ... 2016 , ... "With 30 unique self-animating web themed intros and complete control ... project," said Christina Austin - CEO of Pixel Film Studios. , ProIntro Web ... in Final Cut Pro X. Pixel Film Studios’ minimalistic titles allow users to add ...
(Date:5/28/2016)... ... May 28, 2016 , ... "Color Grading media can ... drop a preset onto their media," said Christina Austin - CEO of Pixel Film ... can quickly and easily add stylish color grades to their footage. A LUT is ...
(Date:5/28/2016)... ... ... year and a half of planning the Multiple Pathways of Recovery Conference , CCAR ... Conference was held May 2 -4, 2016 at the Mystic Marriott Hotel & Spa ... the many pathways individuals use to get into and sustain their recovery. Pathways of ...
(Date:5/27/2016)... ... May 27, 2016 , ... More than a third of ... not surprising that bariatric surgery has received increased attention in recent years, as an ... when it comes to weight loss, most people are familiar with the basic requirements ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... Deutschland und GERMANTOWN, Maryland , ... Zusammenarbeit mit Therawis bedient dringenden ...   QIAGEN N.V. (NASDAQ: ... bekannt, eine Lizenz- und Entwicklungsvereinbarung mit Therawis Diagnostics ... die Onkologie eingegangen zu sein. Ein erstes Projekt ...
(Date:5/25/2016)... YORK , May 25, 2016 ... Market Size, Share, Development, Growth and Demand Forecast to ... Syringe, Insulin Pump and Others)" published by P&S Market ... at $9,998.3 million in 2015, and it is expected ... Based on type, the insulin pump segment is expected ...
(Date:5/25/2016)... 25, 2016 MedDay, a biotechnology company ... an oral presentation entitled "High doses of biotin in progressive ... be given by Professor Ayman Tourbah , Principal Investigator ... the European Academy of Neurology (EAN) in Copenhagen, ... 3" will take place on Sunday, 29 May 2016 from ...
Breaking Medicine Technology: